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K.K.W. Lee, M.J. Stangl, S. Todo, J.M. Langrehr, T.E. Starzl, and W.H. Schraut 
A LTHOUGH small bowel transplantation is the phys-iologic treatment of the short bowel syndrome, Its 
clinical implementation awaits development of immuno-
suppressive regimens that ensure satisfactory control of 
graft rejection. Agents such as Cy A and corticosteroids are 
useful for transplantation of most other vascularized organ 
allografts. However, rejection of the transplanted small 
intestine has been found more difficult to prevent. proba-
bly because the large lymphoid content of the intestine 
renders it more immunogenic and because the bamer 
function of the intestine magnifies defects in immunosup-
pression that would otherwise be inconsequential in trans-
plantation of other organs. Prolonged and, in some in-
stances, indefinite survival of small bowel allografts using 
CyA has been demonstrated in several large and small 
animal models. However. in clinical small bowel trans-
plantation. <~RDTc long-term functional graft survival has 
been achieved when CyA has been used as the primary 
immunosuppressive agent (Grant D, personal communica-
tion. October 1989). demonstrating the need for other more 
effective immunosuppressive agents. 
The macrolide FK 506 has been shown to have potent in 
vitro and in vivo immunosuppressive activity and to delay 
rejection of kidney. I heart. C and Ii ver' allografts in a 
number of experimental animal models. The effectiveness 
of FK 506 has also recently been reported in clinical liver 
and kidney transplantatio~K" To determine whether FK 
506 can effectively prevent the rejection of small bowel 
allografts. studies were undertaken in a rat model of small 
bowel transplantation. 
MATERIALS AND METHODS 
One-stuge orthotopIC small bowel trunsrlantation II a, rer1\,rmcd 
in the fully allogeneic I:lrown :\or\\uI ~oqlnl 10 Lel\j, IRTII) ral 
,train comhination using male rah \Ieighing oetlleen 11010 and 2411 
g. Animals In group I In = 6) received no ImmUnl"Uppre"llc 
Iherary. :\nlmab in group 2 In = 'II rec:elled FK 'Of, at a J",a),!e 
of ~ mgkg intramuscularlv on po,toperative days 0 through 4. For 
companson. ammals in group 3 In = II) receiveJ C\:\ at a d,'sage 
of 15 m!;Lkg intramuscularly on postoperative da\, II through 4: 
thiS dosage has previously heen shown in the same stram ("m"l-
nation to result in slgmficantly prolonged graft and recipient 
survival and occasional (30',) indefinite sun'ival 1.\ hen adminis-
tered on dav~ 0 through 7. and to result uniformll in indefinite 
survival \\ hen funher continued every other dal umil postopera-
tive da) ~eKD S)ngeneic ~ievKiI to LewIS) transplanlatlOn was 
retformed in six animals. 
Transplantation was performed using standard mKfIlsurglCal 
techniques as previously described. After revasculanLation of the 
graft. the recipient's own small bowel was resected and the 
transplanted bowel was anastomosed into intestinal .:ontinllity. 
thereby rendering the recipient nutritionally dependent on the 
transplanted small bowel. Immunosuppression was begun imme-
diately postoperatively. 
RESULTS 
In the absence of immunosuppressive therapy (group I), 
all graft recipients developed acute graft rejection charac-
terized by the development of severe diarrhea and weight 
loss and culminating in a moribund state requiring death of 
the recipient: mean survival was 10.8 :!: 1.4 days. Gross 
and microscopic examination of the intestinal allografts 
showed changes consistent with acute fulminant rejection, 
with necrosis or perforation of the bowel wall associated 
with extensive mucosal destruction and marked cellular 
infiltration of the graft. 
With short courses of CyA therapy (group 3), graft 
rejection was delayed and recipient survival prolonged 
(mean survival. ~4KP :!: 3.9 days): however. long-term sur-
vival. as seen with more prolonged courses of CyA. was 
not observed. After initially appearing healthy and gaining 
weight. these graft recipients developed progressivel¥ 
worsening diarrhea. leading to profound inanition and 
death_ Findings at autopsy were consistent with less ful-
minant rejection. Filmy encapsulation of the grafts was 
evident. and perforation and necrosis of the grafts were 
infrequently seen. Hiqologic examination of the grafts 
demonstrated fibrosis and thickening of the bowel wall. 
In contrast. long-term (> f~l da~ sl functional graft sur-
vival has been achieved in all rah receiving live doses of 
FK 506. with the exception of one rat dying from pneumo-
nia on postoperative da\' 120 who had no gross or micro-
",coric evidence of graft rejeLtil1n or graft-vcrsus-host 
disease. Among the long-term sun'i\lng rats. no clinical 
,igns of graft rejection or graft-\er,us-host disease have 
been observed. When examined at lararotomv 6 months 
after transplantation. the intestinal allografts appeared 
grossi, normal. Full-thickness allograft biopsies demon-
~trated normal architecture with no- evidence of rejection 
(Fig I I. Biopsies of the her and spleen were also histo-
logic'llly normal. with no tindings of periportal infiltration 
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Fig 1. A biopsy of an intestinal allograft in a recipient treated with 
FK 506 on postoperative days 0-4 shows a normal histologic 
appearance 6 months after transplantation. Villi are well-preserved 
and there is no evidence of rejection. 
elr JI,rurtion of "picnic architecture suggestivc Dr ongoing 
elr prior graft-ver~us-host disease. 
Function of thc allografts has been clinically normal. 
Kcclplcnt weight gam has been (llmparahk to age-
79 
matched normal rats and syngeneic controls. Maltose 
absorption from the transplanted bowel. an indicator of the 
integrity of the mucosal brush border enzymes. has not 
differed significantly from controls. Measurements of se-
rum total protein. albumin. triglyceride. and cholesterol 
levels. indicative of the recipient's nutritional state. have 
not differed significantly from the control groups. Mea-
surements of serum glucose. blood urea nitrogen. creati-
nine. and liver enzymes also have not differed significantly 
from the control groups. 
DISCUSSION 
Satisfactory prevention of graft rejection remains the pri-
mary problem in small bowel transplantation. In this model 
of orthotopic small bowel transplantation. very short 
courses of FK 506 effectively controlled the rejection of 
intestinal allografts and prevented the development of 
clinical graft-versus-host disease. while preserving graft 
function sufficiently to permit normal recipient growth and 
to maintain a normal nutritional state. In contrast. equally 
short courses of Cy A in a dosage previously found to result 
in long-term survival when given in extended courses were 
less effective. The results of this study demonstrate that 
FK 506 is a highly potent immunosuppressive agent which 
may be more effective than Cy A and may be useful in 
small bowel transplantation. These findings suggest that 
improved success in clinical small bowel transplantation 
may be possible using FK 506 either alone or in combina-
tion with other established immunosuppressive agents. 
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